Teneligliptin in management of type 2 diabetes mellitus

Teneligliptin is a recently developed oral dipeptidyl peptidase 4 inhibitor indicated for the management of type 2 diabetes mellitus (T2DM) in adults along with diet and exercise. Teneligliptin has been recently available in Japan (Teneria(®)), Argentina (Teneglucon(®)), and India (Tenepure; Teneza)...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Surendra Kumar, Panneerselvam, A, Singh, KP, Parmar, Girish, Gadge, Pradeep, Swami, Onkar C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4993264/
https://www.ncbi.nlm.nih.gov/pubmed/27574456
http://dx.doi.org/10.2147/DMSO.S106133

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4993264/
https://www.ncbi.nlm.nih.gov/pubmed/27574456
http://dx.doi.org/10.2147/DMSO.S106133

Ejemplares similares